A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

Clinical trial NCT07583771 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07583771
Sponsor: Chipscreen Biosciences, Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Non Small Cell Lung Cancer Advanced Solid Tumors Lymphoma Diffuse Large B-Cell Lymphoma (DLBCL)

Start date: 2026-06-01
Primary completion: 2029-08-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.